Enid Kabugho

Effects of Pregnancy and Isoniazid Preventive Therapy on M. tuberculosis Interferon Gamma Response Assays in Women with HIV.

G. Montepiedra, T. Sterling, D. Haas, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women With HIV

G. Montepiedra, T. Sterling, D. Haas, 2021 .

Pharmacokinetics and Drug‐Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping

G. Montepiedra, T. Sterling, D. Haas, 2020, Clinical pharmacology and therapeutics.

Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial.

B. Chi, J. Lindsey, L. Mofenson, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial

G. Montepiedra, L. Mokgatlhe, W. El-Sadr, 2023, BMC Pregnancy and Childbirth.

Validity of Neuropsychological Testing in Young African Children Affected by HIV

M. Boivin, J. Ariansen, B. Laughton, 2018, Journal of Pediatric Infectious Diseases.

Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial.

G. Montepiedra, T. Sterling, G. Theron, 2023, The Lancet. Child & adolescent health.